Fatal adverse events with molecular targeted agents in the treatment of advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials

AIMS: Concerns have increased about the risk of fatal adverse events (FAEs) associated with molecular targeted agents (MTAs) in the treatment of advanced hepatocellular carcinoma (HCC). The purpose of this study is to investigate the overall incidence and risk of FAEs in advanced HCC with administra...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaofei, Wan, Jia, Wu, Zhenping, Tu, Juncai, Hu, Yongtao, Wu, Shuang, Lou, Lianqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151100/
https://www.ncbi.nlm.nih.gov/pubmed/30271119
http://dx.doi.org/10.2147/DDDT.S151241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151100/
https://www.ncbi.nlm.nih.gov/pubmed/30271119
http://dx.doi.org/10.2147/DDDT.S151241

Ejemplares similares